Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 3, Randomized, Open-label Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined with Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence (PIVOT-12)
Haydon, Andrew
(Primary Chief Investigator (PCI))
Hawkins, Cheryl-Ann
(Project Manager)
Medicine Alfred Hospital
Project
:
Research
Overview
Project Details
Status
Active
Effective start/end date
21/04/21
→
31/12/25
View all
View less
Keywords
Melanoma
Immunotherapy
Clinical trial